Skip to main content
Seegnal logo

Seegnal — Investor Relations & Filings

Ticker · SEGN ISIN · CA81573E1060 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 152 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country CA Canada
Listing TSXV SEGN

About Seegnal

https://www.seegnal.com/

Seegnal is a healthcare technology provider specializing in SaaS clinical decision support solutions, marketed as the enterprise Prescription Operating System (Prescription OS). The platform's core function is to mitigate Adverse Drug Effects (ADEs) and reduce patient risk by enabling precision prescribing. Seegnal continuously analyzes prescribing decisions in real-time, leveraging comprehensive clinical context, including patient medications, diagnoses, and lab results. This system delivers measurable clinical ROI and significantly reduces alert fatigue, reportedly lowering alert load by up to 94%. Key modules, such as Seegnal Guard and MetricsGuard, provide real-time, explainable alerts, empowering clinicians while ensuring that all final prescribing decisions remain fully under their control.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 “Venture Issuer Basic Certificate,” containing only an officer’s certification of the annual filings (AIF, financial statements, MD&A). It does not include actual financial statements or substantive data—it is purely an attestation by the CEO. Under the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS).
2026-05-14 English
Annual MD&A - English.pdf
Management Reports Classification · 94% confidence The document is titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for the year ended December 31, 2025. It contains management’s detailed review of financial performance, business trends, risk factors, forward‐looking statements, corporate structure, and operational overview. This is a standalone MD&A section, without the full financial statements themselves, matching the definition of a Management Report (MDA).
2026-05-14 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 87% confidence The document is a completed Form 13-501F1 submitted to the Alberta Securities Commission, consisting primarily of a management certification by the CFO attesting to the accuracy of the information. It is an officer attestation letter rather than a financial report itself. Under the certification rule, such documents are classified as Regulatory Filings (RNS).
2026-05-14 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 95% confidence The document is the standalone audited consolidated financial statements for the years ended December 31, 2025 and 2024, including the independent auditor’s report, balance sheet, comprehensive loss statement, cash flows, and notes. It contains actual audited financial data and audit opinions, not merely an announcement or summary. This fits the definition of an Audit Report / Information. FY 2025
2026-05-14 English
News release - English.pdf
Regulatory Filings
2026-05-06 English
News release - English.pdf
Regulatory Filings
2026-05-01 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.